2025 · 2nd Quarter (Apr 1 - June 30)

BIOTECHNOLOGY INNOVATION ORGANIZATION

Filed by AVOQ, LLC.

Open official filing

Source-reported fields

Filing overview

Type: 2nd Quarter - Report
Posted: Jul 21, 2025
Income: $80,000.00
Expenses: Not reported
Registrant: AVOQ, LLC
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION
Filing UUID: d94cef96-4b18-48f9-8337-d07b8b11c1d9
Termination date: Not reported

Literal source text

Lobbying issues and bill citations

HCR · Health Issues

General issues related to health care, including H.R. 946, Optimizing Research Progress Hope And New Cures Act (ORPHAN) Cures Act and H.R.1, One Big Beautiful Bill Act

Literal federal measure citations: H.R. 946, H.R.1

TRD · Trade (domestic/foreign)

Issues related to international trade

TAX · Taxation/Internal Revenue Code

Issues related to the Vaccine Injury Compensation Program; General tax issues and monitoring of H.R.1, One Big Beautiful Bill Act

Literal federal measure citations: H.R.1

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.